#GlaxoSmithKline
2 articles
crime
Cancer Drug Shows Promise but Raises Concerns Over Cost
GlaxoSmithKline's new cancer drug, Mo-Rez, is showing promise in trials. However, conservatives fear it may be too expensive and out of reach for many patients.
7d ago
crime
GSK's $2.2B Purchase of RAPT Signals Pharma's Growing Stake in Allergy Treatment
GlaxoSmithKline's acquisition of RAPT Pharmaceuticals highlights the pharmaceutical industry's push towards innovative solutions for critical health issues such as food allergies.
89d ago